Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Broeckel

Showing results (51-60 of 125) with videos related to

Pageof 13
Sort By:
Inflammatory Bowel Diseases|September 1, 2007
Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibilityArie Levine, Subra Kugathasan, Vito Annese, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology GroupPatrick Thompson, Heather E Wheeler, Shannon M Delaney, et al.
The Journal of Molecular Diagnostics : JMD|May 21, 2021
Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative ProjectVictoria M Pratt, Amy Turner, Ulrich Broeckel, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Transcriptional Variabilities in Human hiPSC-derived Cardiomyocytes: All Genes Are Not Equal and Their Robustness May Foretell Donor's Disease SusceptibilityC Charles Gu, Andrea Matter, Amy Turner, et al.
The Journal of Molecular Diagnostics : JMD|August 12, 2019
Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative ProjectAndrea Gaedigk, Amy Turner, Robin E Everts, et al.
Pharmacogenomics|December 15, 2016
The impact of the UGT1A1*60 allele on bilirubin serum concentrationsAmy L Pasternak, Kristine R Crews, Kelly E Caudle, et al.
Clinical Pharmacology and Therapeutics|May 9, 2018
Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human LiverDeepak Kumar Bhatt, Aanchal Mehrotra, Andrea Gaedigk, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2014
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centersHenry M Dunnenberger, Kristine R Crews, James M Hoffman, et al.
Nature Genetics|January 31, 2002
A comprehensive linkage analysis for myocardial infarction and its related risk factorsUlrich Broeckel, Christian Hengstenberg, Björn Mayer, et al.
Metabolism: Clinical and Experimental|March 6, 2012
Obesity-insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J miceAldi T Kraja, Heather A Lawson, Donna K Arnett, et al.
Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:
Pageof 13
Inflammatory Bowel Diseases|September 1, 2007
Pediatric onset Crohn's colitis is characterized by genotype-dependent age-related susceptibilityArie Levine, Subra Kugathasan, Vito Annese, et al.
Cancer Chemotherapy and Pharmacology|August 15, 2014
Pharmacokinetics and pharmacogenomics of daunorubicin in children: a report from the Children's Oncology GroupPatrick Thompson, Heather E Wheeler, Shannon M Delaney, et al.
The Journal of Molecular Diagnostics : JMD|May 21, 2021
Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative ProjectVictoria M Pratt, Amy Turner, Ulrich Broeckel, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
Transcriptional Variabilities in Human hiPSC-derived Cardiomyocytes: All Genes Are Not Equal and Their Robustness May Foretell Donor's Disease SusceptibilityC Charles Gu, Andrea Matter, Amy Turner, et al.
The Journal of Molecular Diagnostics : JMD|August 12, 2019
Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative ProjectAndrea Gaedigk, Amy Turner, Robin E Everts, et al.
Pharmacogenomics|December 15, 2016
The impact of the UGT1A1*60 allele on bilirubin serum concentrationsAmy L Pasternak, Kristine R Crews, Kelly E Caudle, et al.
Clinical Pharmacology and Therapeutics|May 9, 2018
Age- and Genotype-Dependent Variability in the Protein Abundance and Activity of Six Major Uridine Diphosphate-Glucuronosyltransferases in Human LiverDeepak Kumar Bhatt, Aanchal Mehrotra, Andrea Gaedigk, et al.
Annual Review of Pharmacology and Toxicology|October 9, 2014
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centersHenry M Dunnenberger, Kristine R Crews, James M Hoffman, et al.
Nature Genetics|January 31, 2002
A comprehensive linkage analysis for myocardial infarction and its related risk factorsUlrich Broeckel, Christian Hengstenberg, Björn Mayer, et al.
Metabolism: Clinical and Experimental|March 6, 2012
Obesity-insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J miceAldi T Kraja, Heather A Lawson, Donna K Arnett, et al.
Pageof 13